Placeholder photo profile
icon-member
Full Member

Emilia Barreto Durán

Membership since: 2025
icon-world
Latin America & Caribbean
|
icon-home
Currently in:
Field of activity:
other-awards
Awards
March 2019 Master's Thesis with Honorable Mention Award. Pontifical Xavierian University. Bogotá, Colombia.
March 2019 Master’s Degree with Honors, Cum laude diploma. Pontifical Xavierian University. Bogotá, Colombia.
November 2018 National Academy of Medicine Scientific Investigation Honorary Mention Award 2018. National Academy of Medicine. Bogotá, Colombia.
October 2019 Marie curie fellowship- Organovir, Organoids for Virus Research - An innovative training-ETN programme.

Degrees:

2016
Undergraduate     Biological Systems and Organisms
2019
Master     Structural, Cell and Molecular Biology

Publications resulting from Research
Barreto-Durán, E., Mejía-Cruz, C. C., Leal-García, E., Pérez-Núñez, R., Rodríguez-Pardo, V. M. (2018) Impact of donor characteristics on the quality of bone marrow as a source of mesenchymal stromal cells. American Journal of Stem Cells, 7(5), 114.
Mejía-Cruz, C. C., Barreto-Durán, E., Pardo-Pérez, M., Jimenez, M., Rincón, J., Vanegas, K., ... & Rodríguez-Pardo, V. M. (2019). Generation of organotypic multicellular spheres by magnetic levitation: Model for the study of human hematopoietic stem cells microenvironment. International Journal of Stem Cells.
Pyrć, K., Milewska, A., Duran, E. B., Botwina, P., Lopes, R., Arenas-Pinto, A., ... & Uchegbu, I. F. (2020). SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray. bioRxiv.

PREPRINT
Synowiec, A., Szczepański, A., Barreto-Duran, E., Lie, L. K., & Pyrc, K. (2021). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clinical Microbiology Reviews, 34(2).
Milewska, A., Chi, Y., Szczepanski, A., Barreto-Duran, E., Dabrowska, A., Botwina, P., ... & Pyrc, K. (2021). HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV. Journal of Virology, 95(4).
Napolitano, V., Dabrowska, A., Schorpp, K., Mourão, A., Barreto-Duran, E., Benedyk, M., ... & Pyrc, K. (2021). Acriflavine, a clinically aproved drug, inhibits SARS-CoV-2 and other betacoronaviruses. bioRxiv.

PREPRINT